Reviva Pharmaceuticals Holdings, Inc.盘中异动股价大跌5.33%

市场透视10-22

北京时间2024年10月22日22时32分，Reviva Pharmaceuticals Holdings, Inc.（RVPH.us）股票出现异动，股价快速下跌5.33%。截至发稿，该股报1.42美元/股，成交量10.6605万股，换手率0.32%，振幅3.33%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-7.86百万美元，每股收益-0.26美元，毛利0.00美元，市盈率-...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2477238355?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-10-22 22:32","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2477238355","market":"us","top_or_hot":-1,"title":"Reviva Pharmaceuticals Holdings, Inc.盘中异动 股价大跌5.33%","media":"市场透视","content":"<div>\n<p>北京时间2024年10月22日22时32分，Reviva Pharmaceuticals Holdings, Inc.（RVPH.us）股票出现异动，股价快速下跌5.33%。截至发稿，该股报1.42美元/股，成交量10.6605万股，换手率0.32%，振幅3.33%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-7.86百万美元，每股收益-0.26美元，毛利0.00美元，市盈率-...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022223214a1e2d2a1&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Reviva Pharmaceuticals Holdings, Inc.盘中异动 股价大跌5.33%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nReviva Pharmaceuticals Holdings, Inc.盘中异动 股价大跌5.33%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-22 22:32 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022223214a1e2d2a1&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年10月22日22时32分，Reviva Pharmaceuticals Holdings, Inc.（RVPH.us）股票出现异动，股价快速下跌5.33%。截至发稿，该股报1.42美元/股，成交量10.6605万股，换手率0.32%，振幅3.33%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-7.86百万美元，每股收益-0.26美元，毛利0.00美元，市盈率-...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022223214a1e2d2a1&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022223214a1e2d2a1&s=b","article_id":"2477238355","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022223214a1e2d2a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2477238355","pubTimestamp":1729607534,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年10月22日22时32分，Reviva Pharmaceuticals Holdings, Inc.股票出现异动，股价快速下跌5.33%。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。其相关个股中，Ensysce Biosciences, Inc.、Genprex, Inc.、Sangamo Therapeutics, Inc.涨幅较大，Genprex, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为4078.61%、3129.18%、1897.31%，振幅较大的相关个股有Ensysce Biosciences, Inc.、Aptevo Therapeutics Inc.、Genprex, Inc.，振幅分别为140.78%、99.41%、81.46%。Reviva Pharmaceuticals Holdings, Inc.公司简介：Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司，致力于发现、开发并寻求商业化治疗药物。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{},"translate_title":"Reviva Pharmaceuticals Holdings, Inc. shares plunged 5.33% after intraday changes","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RVPH":1},"content_text":"北京时间2024年10月22日22时32分，Reviva Pharmaceuticals Holdings, Inc.（RVPH.us）股票出现异动，股价快速下跌5.33%。截至发稿，该股报1.42美元/股，成交量10.6605万股，换手率0.32%，振幅3.33%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-7.86百万美元，每股收益-0.26美元，毛利0.00美元，市盈率-1.08倍。机构评级方面，在所有5家参与评级的机构中，80%的券商给予买入建议，20%的券商给予持有建议，无券商给予卖出建议。Reviva Pharmaceuticals Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。其相关个股中，Ensysce Biosciences, Inc.、Genprex, Inc.、Sangamo Therapeutics, Inc.涨幅较大，Genprex, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm (Holdings) Plc较为活跃，换手率分别为4078.61%、3129.18%、1897.31%，振幅较大的相关个股有Ensysce Biosciences, Inc.、Aptevo Therapeutics Inc.、Genprex, Inc.，振幅分别为140.78%、99.41%、81.46%。Reviva Pharmaceuticals Holdings, Inc.公司简介：Reviva Pharmaceuticals Holdings Inc 是一家后期的制药公司，致力于发现、开发并寻求商业化治疗药物。该公司目前的产品管线主要关注中枢神经系统、炎症和心脏代谢性疾病。该公司利用化学基因组学驱动的技术平台和专有化学方法来开发新药物。该公司目前的产品管线中有两个药物候选品，Brilaroxazine（RP5063）旨在治疗多种神经精神疾病，包括精神分裂症、双相情感障碍、抑郁症、注意力缺陷/多动障碍、老年痴呆或阿尔茨海默病的行为和精神症状，以及帕金森病的精神症状，另一个药物候选品是RP1208。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2477238355"}

Reviva Pharmaceuticals Holdings, Inc.盘中异动 股价大跌5.33%

精彩评论

Reviva Pharmaceuticals Holdings, Inc.盘中异动股价大跌5.33%